Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $582.6900 (-0.78%) ($582.6900 - $586.8200) on Wed. Jul. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.36% (three month average) | RSI | 67 | Latest Price | $582.6900(-0.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(41%) DIA(36%) IWD(36%) SPLV(36%) | Factors Impacting REGN price | REGN will decline at least -0.68% in a week (0% probabilities). VIXM(-21%) UUP(-6%) TBT(-6%) VXX(-5%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.68% (StdDev 1.36%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $585.31(-0.45%) | 10 Day Moving Average | $581.74(0.16%) | 20 Day Moving Average | $571.65(1.93%) | To recent high | -1.2% | To recent low | 21% | Market Cap | $61.782b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |